Subtopic Deep Dive

Living Donor Liver Transplantation
Research Guide

What is Living Donor Liver Transplantation?

Living Donor Liver Transplantation (LDLT) is a surgical procedure where a portion of a healthy donor's liver is resected and transplanted into a recipient with end-stage liver disease.

LDLT addresses organ shortages by enabling living individuals to donate liver segments that regenerate in both donor and recipient. Pioneering work includes Strong et al. (1990) reporting the first successful mother-to-son LDLT (820 citations). Kiuchi et al. (1999) analyzed graft size mismatching impacts in 250 living donor cases (955 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

LDLT expands access to transplantation amid deceased donor shortages, with adult-to-adult procedures reducing waitlist mortality. Kiuchi et al. (1999) showed graft size mismatches increase small-for-size syndrome risk, guiding minimum graft volume thresholds. Strong et al. (1990) demonstrated feasibility in pediatric cases, influencing global protocols. Ojo et al. (2003) highlighted post-transplant renal failure risks (7-21% at five years), emphasizing long-term donor and recipient monitoring (2179 citations). Kamath and Kim (2007) established MELD scoring for recipient prioritization, optimizing outcomes (1629 citations).

Key Research Challenges

Graft Size Mismatching

Small-for-size grafts in adult recipients elevate small-for-size syndrome risk due to portal hypertension overload. Kiuchi et al. (1999) reported worse prognosis with graft-to-recipient weight ratios below 0.8% in 250 cases. Techniques like portal vein modulation seek to mitigate this.

Donor Safety Risks

Donors face hepatectomy complications including biliary leaks and renal impairment. Ojo et al. (2003) found 7-21% chronic renal failure risk post-nonrenal transplants, relevant to liver donors. Long-term donor morbidity requires standardized safety evaluations.

Recipient Long-term Complications

Post-LDLT issues include vascular thrombosis and chronic rejection. Starzl et al. (1982) outlined orthotopic transplantation evolution, noting chimerism's role in acceptance (883 citations). MELD scoring by Kamath and Kim (2007) predicts survival but needs LDLT-specific refinements.

Essential Papers

1.

Chronic Renal Failure after Transplantation of a Nonrenal Organ

Akinlolu Ojo, Philip J. Held, Friedrich K. Port et al. · 2003 · New England Journal of Medicine · 2.2K citations

The five-year risk of chronic renal failure after transplantation of a nonrenal organ ranges from 7 to 21 percent, depending on the type of organ transplanted. The occurrence of chronic renal failu...

2.

The model for end-stage liver disease (MELD)

Patrick S. Kamath, W. Ray Kim · 2007 · Hepatology · 1.6K citations

Abstract The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular i...

3.

Diabetes Mellitus after Kidney Transplantation in the United States

Bertram L. Kasiske, Jon J. Snyder, David T. Gilbertson et al. · 2003 · American Journal of Transplantation · 1.3K citations

5.

IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2

Tetsuya Kiuchi, Mureo Kasahara, Kenji Uryuhara et al. · 1999 · Transplantation · 955 citations

Background. Although living donor liver transplantation for small pediatric patients is increasingly accepted, its expansion to older/larger patients is still in question because of the lack of suf...

6.

AASLD practice guidelines

Karen F. Murray, Robert L. Carithers · 2005 · Hepatology · 947 citations

These recommendations provide a data-supported approach. They are based on the following: (1) formal review and analysis of the recently published world literature on the topic [Medline search]; (2...

7.

Evolution of Liver Transplantation

Thomas E. Starzl, Shunzaburo Iwatsuki, David H. Van Thiel et al. · 1982 · Hepatology · 883 citations

Two general kinds of liver transplantation have been attempted clinically.With one approach, the host liver is removed and replaced with a homograft (orthotopic liver transplantation); alternativel...

Reading Guide

Foundational Papers

Start with Strong et al. (1990) for first successful LDLT case (820 citations), then Kiuchi et al. (1999) for graft size analysis (955 citations), and Starzl et al. (1982) for transplantation evolution (883 citations).

Recent Advances

Study Adam et al. (2012) on European LT trends (847 citations) and Kamath and Kim (2007) MELD model (1629 citations) for outcome predictions.

Core Methods

Core techniques: partial hepatectomy, microvascular anastomosis, graft volumetry via CT. Kiuchi et al. (1999) emphasize GRWR thresholds.

How PapersFlow Helps You Research Living Donor Liver Transplantation

Discover & Search

Research Agent uses searchPapers and citationGraph to map LDLT literature from Kiuchi et al. (1999), revealing 955 citations on graft mismatching. exaSearch uncovers related donor safety studies; findSimilarPapers extends to Strong et al. (1990) pediatric cases.

Analyze & Verify

Analysis Agent employs readPaperContent on Ojo et al. (2003) to extract renal failure rates (7-21%), verified via verifyResponse (CoVe) and runPythonAnalysis for survival curve statistics. GRADE grading assesses evidence quality for donor risk meta-analyses.

Synthesize & Write

Synthesis Agent detects gaps in adult-to-adult LDLT outcomes versus pediatric; Writing Agent uses latexEditText, latexSyncCitations for Kiuchi et al. (1999), and latexCompile for reports. exportMermaid visualizes graft size impact timelines.

Use Cases

"Analyze donor renal failure risks in LDLT using statistics from key papers"

Research Agent → searchPapers('LDLT donor renal failure') → Analysis Agent → readPaperContent(Ojo 2003) → runPythonAnalysis(pandas survival stats) → GRADE-verified risk table output.

"Draft LaTeX review on graft size mismatching in living donor liver transplants"

Synthesis Agent → gap detection(Kiuchi 1999) → Writing Agent → latexEditText(intro) → latexSyncCitations(955 refs) → latexCompile → PDF with cited outcomes.

"Find code for modeling small-for-size syndrome in LDLT simulations"

Research Agent → paperExtractUrls(LDLT models) → paperFindGithubRepo → githubRepoInspect → Code Discovery workflow → validated Python scripts for graft volume simulations.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ LDLT papers, chaining searchPapers → citationGraph → structured report on outcomes since Strong (1990). DeepScan applies 7-step analysis with CoVe checkpoints to verify Kiuchi (1999) mismatch data. Theorizer generates hypotheses on donor selection from ELTR trends (Adam 2012).

Frequently Asked Questions

What defines Living Donor Liver Transplantation?

LDLT involves resecting a liver portion from a living donor for orthotopic transplantation into a recipient, enabling regeneration in both. Strong et al. (1990) reported the first successful pediatric case.

What are key methods in LDLT?

Methods include right or left lobe hepatectomy with vascular anastomoses; portal vein modulation addresses small grafts. Kiuchi et al. (1999) quantified graft size impacts.

What are seminal papers on LDLT?

Strong et al. (1990, 820 citations) detailed the first mother-to-son LDLT; Kiuchi et al. (1999, 955 citations) analyzed 250 cases on size mismatching.

What open problems persist in LDLT?

Challenges include minimizing donor morbidity like renal failure (Ojo 2003) and optimizing adult recipient outcomes beyond MELD (Kamath 2007).

Research Organ Transplantation Techniques and Outcomes with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Living Donor Liver Transplantation with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers